Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
01/07/1993 | WO1993000330A2 Azanorbornane derivatives |
01/07/1993 | WO1993000313A2 Sigma receptor ligands and the use thereof |
01/07/1993 | WO1993000094A2 Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine |
01/07/1993 | WO1993000086A1 Use of tetrahydrocarbazone derivatives as 5ht1 receptor agonists |
01/07/1993 | WO1993000080A1 Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions |
01/07/1993 | WO1993000079A1 Method of preventing and treating chemotherapy-induced alopecia |
01/07/1993 | WO1993000050A1 Pharmaceutical formulations of osteogenic proteins |
01/07/1993 | WO1993000049A1 Osteogenic factor |
01/07/1993 | EP0521768A1 Thiazolopyrimidine derivatives as angiotensin II-receptor antagonists: processes for their preparation and pharmaceutical compositions containing them |
01/07/1993 | EP0521680A1 3-Oxygermylpropionic acid compressed compositon and its use against cytopathogenic substances |
01/07/1993 | EP0521471A1 Pyrimidine derivatives as HMG-CoA reductase inhibitors |
01/07/1993 | EP0521464A1 Antibiotic, phencomycin, a process for its production and its use |
01/07/1993 | EP0521225A1 Pharmaceutical preparation for treatment of periodontitis, containing clavulanic acid |
01/07/1993 | CA2112496A1 Method of preventing and treating chemotherapy-induced alopecia |
01/07/1993 | CA2112250A1 Dimethylamino-hydroxy-alkan diphosphonic acids and pharmaceutical compositions containing them |
01/07/1993 | CA2111957A1 Sigma receptor ligands and the use thereof |
01/07/1993 | CA2111335A1 Azanorbornane derivatives |
01/07/1993 | CA2110575A1 Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine |
01/07/1993 | CA2093790A1 Osteogenic factor |
01/06/1993 | CN1067656A Aminomethyl-substituted 2,3-dihydropyrano (2,3-b) pyridines, process for their preparation and their use in medicaments |
01/06/1993 | CN1067578A Non-chlorofluorocarbon aerosol formulations |
01/06/1993 | CA2072676A1 Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy |
01/05/1993 | US5177257 Racemic separation, quinine salt formation |
01/05/1993 | US5177104 6-α-hydroxy derivatives of mevinic acids |
01/05/1993 | US5177079 Antiallergen, antiulcer |
01/05/1993 | US5177078 Piperazine derivatives |
01/05/1993 | US5177074 Angiotensin ii antagonists incorporating a substituted thiophene or furan |
01/05/1993 | US5177064 Targeted drug delivery via phosphonate derivatives |
01/05/1993 | US5177017 Molecular cloning of the genes responsible for collagenase production from Clostridium histolyticum |
01/05/1993 | CA1312333C Strontium salt, its preparation process and the pharmaceutical compositions containing it |
01/04/1993 | CA2072775A1 Substituted triazolinones |
01/03/1993 | WO1993001166A1 4-amino-3-hydroxycarboxylic acid derivatives |
01/03/1993 | CA2109326A1 4-amino-3-hydroxycarboxylic acid derivatives |
01/02/1993 | CA2072834A1 Ketone derivatives |
12/30/1992 | EP0520724A1 Angiotensin II antagonists |
12/30/1992 | EP0520573A1 Cyclic imide derivatives |
12/30/1992 | EP0520555A1 Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy |
12/30/1992 | EP0520427A1 Cyclopropenone derivatives |
12/30/1992 | EP0520423A2 Heterocyclic compounds, their production and use as angiotensin II antagonists |
12/30/1992 | EP0520325A1 Use of monoamine oxidase-B-inhibitors for the prevention and treatment of withdrawal symptoms after alcohol and drug abuse |
12/30/1992 | EP0520112A1 Dermatological composition based on an aqueous phase |
12/30/1992 | EP0519996A1 Imidazoles |
12/30/1992 | EP0211863B1 Vitamin d derivatives and methods for preparing same |
12/30/1992 | CN1067428A 奎宁环衍生物 Quinuclidine derivatives |
12/29/1992 | WO1993001286A2 Localized oligonucleotide therapy |
12/29/1992 | US5175264 5-[4-(4,6-dimethyl-2-pyrimidinylsulfamoyl)phenylazo]acetylsalicylic acid |
12/29/1992 | US5175253 Serpin-enzyme complex receptor binding pentapetides |
12/29/1992 | US5175166 Cognition activators |
12/29/1992 | US5175164 Angiotensin ii antagonists incorporating a substituted indole or dihydroindole |
12/29/1992 | US5175153 Antiischemic agents or antiepileptic agents |
12/29/1992 | US5175096 Dna encoding a fibronectin binding protein as well as its preparation |
12/29/1992 | CA1312083C Hydantoin derivatives |
12/29/1992 | CA1312076C2 Prodrugs of rapamycin |
12/29/1992 | CA1312015C Antiparkinson ergoline derivatives |
12/29/1992 | CA1312012C Compositions and methods for treating gastrointestinal disorders |
12/28/1992 | CA2072551A1 Cyclic imide derivatives |
12/26/1992 | CA2072215A1 New substituted azetidinones as anti-inflammatory and antidegenerative agents |
12/26/1992 | CA2071086A1 Heterocyclic compounds |
12/25/1992 | CA2071800A1 Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy |
12/24/1992 | DE4120213A1 Monoclonal antibodies against TNF-BP I - used for immunoassays to detect TNF-BP I in diagnosis of bacterial infection septic shock, graft versus host disease and cerebral malaria |
12/23/1992 | WO1992022664A1 Chemotactic factor |
12/23/1992 | WO1992022584A1 Monoclonal antibodies specific for marrow-derived mesenchymal cells |
12/23/1992 | WO1992022569A1 Peptides with tachykinin antagonist activity |
12/23/1992 | WO1992022543A1 N-hydroxyurea derivatives which inhibit lipoxygenase |
12/23/1992 | WO1992022542A1 Aminoalkyl-substituted 2-amino-5-mercaptothiadiazoles, their preparation and their use |
12/23/1992 | WO1992022541A1 Aminoalkyl-substituted 2-amino-1,3,4-thiadiazoles, their preparation and their use |
12/23/1992 | WO1992022534A1 Alzheimer's disease treatment with tacrine metabolites |
12/23/1992 | WO1992022312A1 Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer |
12/23/1992 | WO1992022311A1 New medicinal use of igf-ii |
12/23/1992 | WO1992022307A1 Remedy for chronic fatigue syndrome |
12/23/1992 | WO1992022296A1 Use of atipamezole for the treatment of male sexual impotence |
12/23/1992 | WO1992022294A1 Immunomodulatory azaspiranes |
12/23/1992 | WO1992022288A1 Non-chlorofluorocarbon aerosol formulations |
12/23/1992 | WO1992019224A3 Anti-free-radical topical composition based on a superoxide dismutase and a phosphonic derivative |
12/23/1992 | EP0519831A1 N-Substituted heterocyclic derivatives, their preparation, and pharmaceutical compositions containing them |
12/23/1992 | EP0519819A1 Composition for use to reduce hair loss and to induce and stimulate its growth, containing derivatives of 2,4,6-triaminopyrimidin-N-oxide and the new derivatives of 2,4,6-triaminopyrimidin-N-oxide |
12/23/1992 | EP0519673A1 Composition containing dioxabicyclo[3.3.0]octane derivative |
12/23/1992 | EP0519463A1 Synthetic, catalytic oligonucleotides |
12/23/1992 | EP0519434A2 Heterocyclic compounds with renin inhibiting properties, process for their preparation and their use |
12/23/1992 | EP0519433A1 Compounds with renin-inhibiting properties, process for their preparation and their use |
12/23/1992 | EP0519353A2 Indolizin derivatives, process for their preparation and pharmaceutical composition containing them |
12/23/1992 | EP0519291A1 Amino-methyl substituted 2,3-Dihydropyrano (2,3-b) pyridines, process for their preparation and their use in medicines |
12/23/1992 | EP0518951A1 Phenyl butyl nitrone compositions for prevention of gastric ulceration |
12/23/1992 | EP0518943A1 Mercaptoacyl aminolactam endopeptidase inhibitors |
12/23/1992 | EP0518933A1 Leukaemia inhibitory factor |
12/23/1992 | EP0377613B1 Conjugates of superoxide dismutase |
12/23/1992 | CN1067244A Pyrrolidones |
12/23/1992 | CA2111464A1 The use of igf-ii for the regeneration of cardiac or smooth muscle tissues |
12/23/1992 | CA2111442A1 Aminoalkyl-substituted 2-amino-5-mercaptothiadiazoles the preparation and use thereof |
12/23/1992 | CA2111440A1 Aminoalkyl-substituted 2-amino-1,3,4-thiadiazoles, the preparation and use thereof |
12/23/1992 | CA2110577A1 Immunomodulatory azaspiranes |
12/22/1992 | US5173502 For treating depression, hypertension, parkinson*s disease, asthma, convulasions, platelet aggregation of metabolic disorders |
12/22/1992 | US5173493 For treatment or prevention of nausea or vomiting |
12/22/1992 | US5173487 Mevinic acid derivatives |
12/22/1992 | US5173486 Dibenz[b,f][1,4]oxazepin-11(10H)-ones for multidrug resistance reversing agents |
12/22/1992 | US5172481 Electronic inclinometer |
12/22/1992 | CA2071744A1 Compounds with renin-inhibiting properties, a process for the preparation thereof and the use thereof |
12/22/1992 | CA2071743A1 Heterocyclic compounds with renin-inhibiting properties, a process for the preparation thereof and the use thereof |
12/22/1992 | CA1311767C 5-substituted ornithine derivatives |
12/21/1992 | CA2071802A1 Composition for slowing the rate of falling hair and inducing and stimulating hair growth, containing pyrimidines n-oxyde trisubstituted in 2,4 and 6 with an amine functionality or their sulfoconjugated derivatives, novel pyri idines n-oxyde compounds or their sulfoconjugated derivatives |